ホルモン補充療法市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00003836
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

ホルモン補充療法の市場予測は、この市場の関係者が成長戦略を概説するのに役立ちます。 市場は、2023 年の 84 億 6,000 万米ドルから 2031 年までに 148 億 2,000 万米ドルに成長すると予測されています。 2023 年から 2031 年にかけて 7.3% の CAGR を記録すると推定されています。

ホルモン補充療法 (HRT) の世界的な需要は、次のような要因により着実に増加しています。ホルモン障害の有病率の増加、ホルモン欠乏症に対する意識の高まり、HRT製剤の改善。明らかな安全性と有効性の利点により、生物学的同一ホルモン補充療法 (BHRT) は合成ホルモンよりも人気が高まっています。 BHRT は天然源に由来するため、体が自然に生成するホルモンによりよく似ていると考えられています。

製薬会社は、次のような新しいホルモン療法製剤の開発に投資しています。患者の利便性、コンプライアンス、および安全性プロファイルを向上させるための経皮パッチ、ゲル、クリーム、および皮下インプラント。この要因がホルモン補充療法市場の成長を推進します。 2023年8月、食品医薬品局(FDA)はANIファーマシューティカルズの0.1%エストラジオールゲルの短縮新薬申請を承認した。参考文献に掲載されている薬剤 Divigel は、更年期障害に伴う中等度から重度の血管運動神経症状の治療に使用されるエストロゲンホルモン療法です。 Divigel の一般的な形式は、0.1% のエストラジオール ゲルです。

成長ドライバー:

幅広い応用がホルモン補充療法市場の成長を促進

ホルモン補充療法は、更年期障害の症状や成長ホルモンの治療に処方されています。欠乏症など、生活に重大な影響を及ぼす可能性があります。何百万人もの女性が HRT を、時には長期間にわたって使用しています。 HRT は、さまざまな方法で骨粗鬆症を予防し、生活の質を向上させることができます。オレゴン州保健局によると、サイエンス大学によれば、成長ホルモン欠乏症 (GHD) は一般的ではなく、米国の成人約 50,000 人、子供約 4,000 ~ 6,000 人に 1 人が罹患しています。したがって、さまざまなホルモン疾患の有病率の増加と相まって、この療法の使用の増加が、ホルモン補充療法治療市場の成長を促進します。

抑制:

高価格の薬剤がホルモン補充療法市場の成長を妨げている

HRT 製品のコストは比較的高価です。たとえば、更年期障害センターによると、経口ホルモン補充療法の処方箋の価格は、月額 130 米ドルから 240 米ドル (つまり、年間 1,560 米ドルから 2,440 米ドル) の範囲です。コストが高いため、これらの製品を定期的に使用することができず、ホルモン補充療法市場の成長が抑制されています。

戦略的分析情報

レポートの分割と範囲:

ホルモン補充療法市場分析は、治療、適用、投与経路、エンドユーザーの各セグメントを考慮して実施されました。

< p>ホルモン補充療法市場は、治療法別に、エストロゲンホルモン補充、成長ホルモン補充、甲状腺ホルモン補充、テストステロン補充などに分割されています。エストロゲン ホルモン補充療法セグメントは、2023 年に最大の市場シェアを保持しました。

ホルモン補充療法 市場、用途別、更年期障害、成長ホルモン(GH)欠乏症、甲状腺機能低下症、性腺機能低下症などに分類されます。更年期障害セグメントは、2023 年にホルモン補充療法市場で最大のシェアを保持しており、予測期間中に最高の CAGR を記録すると予想されています。

地域分析:

地域に関しては、ホルモン補充療法の市場レポートの範囲には以下が含まれます。北米、ヨーロッパ、アジア太平洋、南および南。中央アメリカ、中東、およびアフリカ。 2023 年、北米が最大の市場シェアを保持しました。最新技術の導入の増加、ホルモン疾患の有病率の上昇、新製品の早期導入、主要な市場プレーヤーの存在が、北米におけるホルモン補充療法の市場規模の急増に貢献しています。 2023年6月、週1回投与のヒト成長ホルモン類似体であるNGENLA(ソマトロゴン-GHLA)が、栄養不足が原因で成長障害を起こしている3歳以上の小児患者の治療に使用するために米国食品医薬品局(FDA)によって承認された。ファイザー社とOPKO Health Inc.が発表した声明によると、内因性成長ホルモンの分泌。

さらに、質の高い個別化されたケアへのアクセスを提供し、健康管理を強化することへの注目が高まっています。ヘルスケアソリューションは、予測期間中にホルモン補充療法市場に大きな機会を生み出すでしょう。 2023 年 5 月、テキサス州最大のホルモン補充クリニック ネットワークの 1 つであるホルモン バイ デザインが、統合医療および機能性医療提供者の初の全国ネットワークであるフォーラム ヘルス LLC に買収されました。

業界の発展と将来の機会:

ホルモン補充療法市場で活動する主要企業による戦略的発展企業のプレスリリースによると、以下のとおりです。

    •2024 年 1 月、デンマークの Ascendis Pharma A/S と Vector Pharma FZCO ( Vector) は、サウジアラビア、UAE、クウェート、オマーン、カタール、バーレーンの湾岸協力会議 (GCC) 諸国で Yorvipath と Skytrofa を商品化するための独占販売契約を締結しました。この独占的販売契約の条件に従って、ベクターはその販売およびマーケティングの経験を活用して、GCC 諸国の患者に、ヨーヴィパスの成人副甲状腺機能低下症および小児成長ホルモン欠乏症 (GHD) の治療用のヨーヴィパスとスカイトロファを提供します。 Skytrofa の場合。

共同競争力のある景観と主要企業:< /strong>

アストラゼネカ;ファイザー株式会社;ノバルティスAG;アボット。トルマー株式会社;パー・ファーマシューティカル。メイン ファーマ グループ リミテッド;ノボ ノルディスク A/S;イーライリリーアンドカンパニー。および Noven Pharmaceuticals, Inc.は、ホルモン補充療法の市場レポートで紹介されている著名な企業の 1 つです。これらの企業は、世界中で高まる消費者の需要に応えるために、新技術の開発、既存製品のアップグレード、地理的プレゼンスの拡大に重点を置いています。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is hormone replacement therapy?

Medication that contains female hormones is known as hormone replacement treatment. When you go through menopause, your body stops producing estrogen, so you take medication to replace it. The most common menopausal symptoms that hormone therapy is used to treat are hot flashes and vaginal discomfort.

Who are the major players in the hormone replacement therapy market?

The hormone replacement therapy market majorly consists of the players, including Astrazeneca, Pfizer Inc., Novartis AG, Abbott, Tolmar Inc, Par Pharmaceutical, Mayne Pharma Group Limited, Novo Nordisk A/S, Eli Lily And Company, and Noven Pharmaceuticals, Inc.

What are the growth estimates for the hormone replacement therapy market till 2031?

The hormone replacement therapy market is expected to be valued at US$ 14.82 billion in 2031.

What was the estimated hormone replacement therapy market size in 2023?

The hormone replacement therapy market was valued at US$ 8.46 billion in 2023.

What factors drive the hormone replacement therapy market?

Increasing use of hormone replacement therapy products and increasing prevalence of hormone disorder propel the hormone replacement therapy market growth. However, high cost of medications hampers the growth of the market.

Which application segment dominates the hormone replacement therapy market?

The market, by distribution channel, is categorized into menopause, growth hormone (GH) deficiency, hypothyroidism, hypogonadism, and others. The menopause segment held the largest menopause market share in 2023, and it is anticipated to register the highest CAGR during the forecast period.

Which therapy segment dominates the hormone replacement therapy market?

By therapy, the market is segmented into estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, testosterone replacement, and others. The estrogen hormone replacement segment held a larger hormone replacement therapy market share in 2023.

The List of Companies - Hormone Replacement Therapy Market

  1. Astrazeneca
  2. Pfizer Inc.
  3. Novartis AG
  4. Abbott
  5. Tolmar Inc
  6. Par Pharmaceutical
  7. Mayne Pharma Group Limited
  8. Novo Nordisk A/S
  9. Eli Lily And Company
  10. Noven Pharmaceuticals, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports